Schizophrenie im Alter

Detlef Wietelmann

doi:10.1055/a-2496-7875

Geriatrie up2date, Inhaltsverzeichnis

Geriatrie up2date 2025; 07(02): 93-112
DOI: 10.1055/a-2496-7875

Neurologie und Psychiatrie

Schizophrenie im Alter

Detlef Wietelmann

Abstract

Alle Artikel dieser Rubrik

Die Diagnosestellung der Schizophrenie im Alter ist im Vergleich zu jüngeren Patienten komplexer und mit größeren Unsicherheiten behaftet, was auch das Akronym der VLOSLP (very late-Onset Schizophrenia-like Psychosis) zeigt. Psychiatrische und somatische Kenntnisse über Differenzialdiagnosen, diagnostische Verfahren und Besonderheiten der pharmakologischen Behandlung im Alter helfen, um dieser Patientengruppe gerecht zu werden.

Schlüsselwörter

VLOSLP - very late Onset Schizophrenia like Psychosis - psychotische Erkrankungen - Psychopharmaka - ICD

Volltext

Referenzen

Literatur
1 Tampi RR, Young J, Hoq R. et al. Psychotic disorders in late life: a narrative review. Ther Adv Psychopharmacol 2019; 9
2 Howard R, Rabins PV, Seeman MV. et al. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An international consensus. The International Late-onset Schizophrenia Group. Am J Psychiatry 2000; 157: 172-178
3 Häfner H, Löffler W, Riecher-Rössler A. et al. Schizophrenie und Wahn im höheren und hohen Lebensalter. Nervenarzt 2001; 72: 347-357
4 AWMF. S3-Leitlinie Schizophrenie 2019; AWMF-Register Nr. 038–009. Zugriff am 10. März 2025 unter: https://register.awmf.org/assets/guidelines/038–009l_S3_Schizophrenie_2019–03.pdf
5 Stafford J, Dykxhoorn J, Sommerlad A. et al. Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study. Psychol Med 2021; 53: 750-758
6 Isohanni M, Jääskeläinen E, Koponen H. et al. Antipsychotics in late-life schizophrenia – a narrative review. Psychiatria Fennica 2020; 51: 16-27
7 Bleuler M. Fortschritte der Neurologie und Psychiatrie. 1943
8 Riecher-Rössler A, Rössler W, Förstl H. et al. Late-onset schizophrenia and late paraphrenia. Schizophrenia Bull 1995; 21: 345-354
9 Adityanjee MD, Aderibigbe YA, Theodoridis D. et al. Dementia praecox to schizophrenia:The first 100 years. Psychiatry Clin Neurosci 1999; 53: 437-448
10 Klöppel S, Savaskan E. Psychosen im Alter. Göttingen: Hogrefe; 2021
11 Maina G, Aragno E. Late-life psychosis in women and men. Ital J Gender-Specific Med 2019; 5: 82-89
12 Ismail Z, Creese B, Aarsland D. Psychosis in Alzheimer disease – mechanism, genetics and therapeutic opportunities. Nature Rev Neurol 2022; 18: 131-144
13 Regala J, Moniz-Pereira F. Very late-onset schizophrenia-like psychosis: A case report and critical literature review. Ann Geriatr Med Res 2023; 27: 175-178
14 Monji A, Mizoguchi Y. Neuroinflammation in late-onset schizophrenia: Viewing from the standpoint of the microglia hypothesis. Neuropsychobiol 2022; 81: 98-103
15 Creese B, Vassos E, Bergh S. et al. Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer’s disease. Translational Psychiatry 2019; 9: 273
16 Lauriola M, D’Onofrio G, Ciccone F. et al. Vascular schizophrenia-like psychosis in older adults. J Clin Med 2023; 12: 4831
17 Stepien-Wyrobiec O, Nowak M, Wyrobiec G. et al. Crossroad between current knowledge and new perspective of diagnostic and therapy of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: An update. Front Psychiatry 2022; 13: 1-12
18 van Os J, Howard R, Takei N. et al. Increasing age is a risk factor for psychosis in the elderly. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 161-164
19 Talaslahti T. Finnish older patients with schizophrenia. Acta Universatis Tamperensis 2015; 2104 (Dissertation).
20 Häfner H, Maurer K, an der Heiden W. Schizophrenie – eine einheitliche Krankheit? Ergebnisse aus 25 Jahren ABC-Studie. Nervenarzt 2013; 84: 1093-1103
21 Hsu MC, Lee SC, Ouyang WC. Use of Charlson Comorbidity Index and nomogram to predict mortality in elderly patients with late-life schizophrenia. Healthcare 2021; 9: 783
22 Sin Fai Lam CC, Reeves SJ, Stewart R. et al. Service and treatment engagement of people with very late-onset schizophrenia-like psychosis. B J Psych Bulletin 2016; 40: 185-186
23 Van Assche L, Morrens M, Luyten P. et al. The neuropsychology and neurobiology of late onset schizophrenia and very-late schizophrenia-like psychosis: a critical review. Neurosci Biobehav Rev 2017; 83: 604-621
24 Yang VX, Sin Fai Lam CC, Kane JPM. Cognitive impairment and development of dementia in very late-onset schizophrenia-like psychosis: a systematic review, Ir. J Psychol Med 2021; 30: 1-13
25 Satake Y, Kanemoto H, Yoshiyama K. et al. Case report: Usefulness of biomarkers for Alzheimerʼs disease in two cases with very-late-onset schizophrenia-like psychosis. Front Psychiatry 2021; 12: 742659
26 Van Assche L, van Aubel E, van de Ven F. et al. The neuropsychological profile and phenomenology of late onset psychosis: A cross-sectional study on the differential diagnosis of very-late-onset-schizophrenia-loke-psychosis, dementia with Lewy bodies and Alzheimerʼs type dementia with psychosais. Arch Clin Neuropsychol 2019; 34: 183-199
27 González-Rodrígez A, Seeman MV, Izquierdo E. et al. Delusional disorder in old age: A hypothesis-driven review of recent work focusing on epidemiology, clinical aspects, and outcomes. Int J Environ Res Public Health 2022; 19: 7911
28 Keshavan SK, Kaneko Y. Secondary psychoses: an update. World Psychiatry 2013; 12: 4-15
29 Nebhinani N, Pareek V, Grover S. Late-life psychosis: An overview. J Geriatr Ment Health 2014; 1: 60-70
30 Creese B, Arathimos R, Aarsland D. et al. Late-life onset psychotic symptoms and incident cognitive impairment in people without dementia: Modification by genetic risk for Alzheimerʼs disease. Alzheimers Dement (NY) 2023; 9: e12386
31 Kanemoto H, Satake Y, Suehiro T. et al. Characteristics of very late-onset schizophrenia-like psychosis as prodromal dementia with Lewy bodies: a cross-sectional study. Alzheimer’s Res Ther 2022; 14: 137
32 Jaini A, Yomtoob J, Yeh C. et al. Understanding HD psychosis: An analysis from the Enroll-HD Database. Tremor Other Hyperkinet Mov 2020; 10: 16
33 Windhager E, Glück K, Windhager I. et al. Differenzialdiagnosen der akuten und alkut-transienten psychotischen Störung. J Neurol Neurochir Psychiatr 2021; 22: 18-29
34 Rogowska M, Thornton M, Creese B. et al. Implications of adverse outcomes associated with antipsychotics in older patients with dementia: A 2011–2022 Update. Drugs Aging 2023; 40: 21-32
35 Huhn M, Nikolakopoulou A, Schneider-Thoma J. et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet 2019; 394: 939-951
36 Iglewicz A, Meeks TW, Jeset DV. New wine in old bottle: Late-life psychosis. Psychiatr Clin North Am 2011; 34: 295-318
37 Scott J, Greenwald BS, Kramer E. et al. Atypical (second generation) antipsychotic treatment response in very late-onset schizophrenia-like psychosis. Internat Psychogeriatrics 2011; 23: 742-748
38 Zolk O, Greiner T, Schneider M. et al. Antipsychotic drug treatment of schizophrenia in later life: Results from the European cross sectional AMSP study. World J Biol Psychiatry 2022; 23: 374-386
39 Kratz T, Diefenbacher A. Psychopharmakotherapie im Alter, Vermeidung von Arzneimittelinteraktionen und Polypharmazie. Dtsch Arztebl Int 2019; 116: 508-518
40 Seeman M. Prevention of antipsychotic side effects in elderly population. J Ment Health Aging 2018; 2: 24-27
41 Castberg I, Westin AA, Skogvoll E. et al. Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone and quetiapine. Acta Psychiatr Scand 2017; 136: 455-464
42 MacKenzie NE, Kowalchuk C, Agarwal SM. et al. Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia. Front Psychiatry 2018; 9: 622
43 Jönsson AK, Schill J, Olsson H. et al. Venous thromboembolism during treatment with antipsychotics: A review of current evidence. CNS Drugs 2018; 32
44 Kheirbek RE, Fokar A, Little JT. et al. Association between antipsychotics and all-cause mortality among community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2019; 74: 1916-1921
45 Schneeweiss S, Setoguchi S, Brookhart A. et al. Risk of death associated with the use of conventional versus atypical antipsychotic drugs among elderly patients. CMAJ 2007; 176: 627-632
46 Higgins JM, San C, Lagnado G. et al. Incidence and management of clozapine-induced myocarditis in a large tertiary hospital. Can J Psychiatry 2019; 64: 561-567
47 Ponsford M, Castle D, Tahir T. et al. Clozapine is associated with secondary antibody deficiency. Br J Psychiatry 2019; 214: 83-89
48 Dabbert D, Toto S, Seifert J. Clozapin aus Sicht des Projektes „Arzneimittelsicherheit in der Psychiatrie“. InFo Neurologie Psychiatrie 2022; 24: 40-51
49 Habib-Mayer S, Weigl A, Schneider I. Anstieg des Clozapin-Spiegels im Rahmen eines brochopulmonalen Infektes. Krankenhauspharmazie 2021; 42: 153-155
50 Wagner E, McMahon L, Falkai P. et al. Impact of smoking behavior on clozapine blood levels – a systematic review and meta-analysis. Acta Psychiatr Scand 2020; 142: 456-466
51 Khan W, Rajji T. Schizophrenia in later life: Patient characteristics and treatment strategies. Psychiatric Times 2019; 36: 3
52 Lin CH, Chen FC, Chan HY. et al. A comparison of long-acting injectable antipsychotics with oral antipsychotics on time to rehospitalization within 1 year of discharge in elderly patients with schizophrenia. Am J Geriat Psychiatry 2020; 28: 23-30
53 Benkert O, Hippius H. Kompendium der Psychiatrischen Pharmakotherapie. 13. Aufl. Heidelberg: Springer Verlag; 2021
54 Markota M, Rummans TA, Bostwick JM. et al. Benzodiazepine use in older adults: Dangers, management, and alternative therapies. Mayo Clin Proc 2016; 91: 1632-1639
55 Batra A, Havemann-Reinecke U. AWMF. Medikamentenbezogene Störungen. 1. Aufl. 2020 AWMF-Register-Nr.: 038–025 Zugriff am 10. März 2025 unter: https://register.awmf.org/assets/guidelines/038–025l_S3_Medikamtenbezogene-Stoerungen_2021–01.pdf
56 Liu AY, Rajji TK, Blumberger DM. et al. Brain stimulation in the treatment of late-life severe mental illness other than unipolar nonpsychotic depression. Am J Geriatr Psychiatry 2014; 22: 216-240
57 Rajagopalan A, Kwong Lim KW, Tan XW. et al. Predictors of cognitive changes in patients with schizophrenia undergoing electroconvulsive therapy. PLoS ONE 2023; 18: e0284579
58 Kumagaya D. Acute electroconvulsive therapy in the elderly with schizophrenia and schizoaffective disorder: A case series. Asia-Pacific Psychiatry 2019; 11: e12361
59 Rhee TG, Sint K, Olfson M. et al. Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare Patients. Am J Psychiatry 2021; 178: 1089-1097
60 Talaslahti T, Alanen H-M, Hakko H. et al. Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia. Int J Geriatr Psychiatry 2015; 30: 453-459
61 Knorr R, Hoffmann K. Suizidalität bei schizophrenen Psychosen: eine aktuelle Übersicht. Nervenarzt 2021; 92
62 Yang XV, Sin Fai Lam CC, Kane JPM. Cognitive impairment and development of dementia in very late-onset schizophrenia-like psychosis: a systematic review. Ir J Psychol Med 2021; 1-13
63 El Miniawi S, Orgeta V, Stafford J. Non-affective psychotic disorders and risk of dementia: a systematic review and meta-analysis. Psychological Medicine 2022; 52: 1-13
64 Maglione J, Vahia I, Jeste D. Schizophrenia Spectrum and Other Psychotic Disorders. In: Steffens D. et al. , Hrsg. American Psychiatric Publishing Textbook of Geriatric Psychiatry. 5th ed. Washington DC: American Psychiatric Association Publishing; 2015: 309-332